NCT05816356View on ClinicalTrials.gov

To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

October 10, 2023

Conditions
Healthy
Interventions
DRUG

Decitabine

Oral administration of decitabine as a single dose to healthy male subjects

DRUG

Tetrahydrouridine

Oral administration of Tetrahydrouridine as a single dose to healthy male subjects

Trial Locations (1)

78217

Worldwide Clinical Trails Early Phase Services, San Antonio

Sponsors

Lead Sponsor

EpiDestiny, Inc.

Collaborators (1)

Worldwide Clinical Trials
All Listed Sponsors
collaborator

Worldwide Clinical Trials

OTHER

lead

EpiDestiny, Inc.

INDUSTRY